Ironwood Pharmaceuticals (IRWD) Capital Leases (2010 - 2018)

Ironwood Pharmaceuticals has disclosed Capital Leases across 9 years of filings, most recently posting $158000.0 for Q4 2018.

• In Q4 2018, Capital Leases changed N/A year-over-year to $158000.0; the TTM figure through Dec 2018 stood at $158000.0 (changed N/A YoY), while the FY2018 annual figure was $158000.0, changed N/A from the prior year.
• Capital Leases came in at $158000.0 for Q4 2018 at Ironwood Pharmaceuticals, up from $21000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $3.2 million in Q2 2014 to a low of $21000.0 in Q1 2017.
• Average Capital Leases over 5 years is $1.3 million, with a median of $687000.0 recorded in 2015.
• Year-over-year, Capital Leases soared 1494.95% in 2014 and plunged 91.7% in 2017.
• Over 5 years, Capital Leases stood at $2.6 million in 2014, then slumped by 88.1% to $306000.0 in 2015, then sank by 73.2% to $82000.0 in 2016, then tumbled by 74.39% to $21000.0 in 2017, then jumped by 652.38% to $158000.0 in 2018.
• Per Business Quant data, the three most recent Capital Leases figures were $158000.0 in Q4 2018, $21000.0 in Q1 2017, and $82000.0 in Q4 2016.